Vial Availability

The most vial strength options of any FACTOR VIII replacement therapy. 1-14

ELOCTATE is the only extended half-life therapy with 4000-IU, 5000-IU and 6000-IU dosage strengths. Having all these options means patients may be able to achieve their recommended dose with a single vial.*

Talk to your doctor to see what option may be best for you. When infusing, refer to the Reconstitution video below.

*Dosing and frequency may vary based on individual patient response.

Vials

Image not representative of actual drug product vials.

For more information about safe sharps disposal, go to the FDA's website at:

  • 1. ADVATE ® [package insert]. Westlake Village, CA: Baxalta US Inc; 2016.

  • 2. AFSTYLA ® [package insert]. Kankakee, IL: CSL Behring LLC; 2017.

  • 3. ALPHANATE ® [package insert]. Los Angeles, CA: Grifols Biologicals Inc; 2015.

  • 4. HEMOFIL M ® [package insert]. Westlake Village, CA: Baxalta US Inc; 2016.

  • 5. HUMATE-P ® [package insert]. Kankakee, IL: CSL Behring LLC; 2017.

  • 6. KOATE ®-DVI [package insert]. Research Triangle Park, NC: Grifols Therapeutics Inc; 2012.

  • 7. KOGENATE FS ® [package insert]. Whippany, NJ: Bayer HealthCare LLC; 2016.

  • 8. KOVALTRY ® [package insert]. Whippany, NJ: Bayer HealthCare LLC; 2016.

  • 9. MONOCLATE-P ® [package insert]. Kankakee, IL: CSL Behring LLC; 2014.

  • 10. NOVOEIGHT ® [package insert]. Plainsboro, NJ: Novo Nordisk Inc; 2016.

  • 11. NUWIQ ® [package insert]. Hoboken, NJ: Octapharma USA, Inc; 2015.

  • 12. RECOMBINATE ® [package insert]. Westlake Village, CA: Baxalta US Inc; 2017.

  • 13. REFACTO ® [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2007.

  • 14. XYNTHA ® [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2014.

when infusing eloctate, refer to this reconstitution video

when infusing eloctate, refer to this reconstitution video

Get informed. Stay informed.

Let's stay in touch. We'll occasionally send you important information on Hemophilia A and ELOCTATE. If you're new to ELOCTATE, we'll send you a Bluetooth® speaker so you can listen to patient stories, or if you're already on ELOCTATE, a cooler bag for your product.

Bluetooth is a registered trademark of Bluetooth SIG, Inc. All rights reserved.

Bluetooth is a registered trademark of Bluetooth SIG, Inc. All rights reserved.

×

INDICATION ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indication 

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

INDICATION

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Important Safety Information and Indication 

IMPORTANT SAFETY INFORMATION

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly.

Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort.

If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk.

These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE.

INDICATION

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.

Please see Full Prescribing Information

MANUFACTURED BY

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078

Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.